Sfondo Header
L'angolo del dottorino
Search the site... Advanced search
✖

How long does pericarditis last?
Recovery and healing times

In most uncomplicated acute forms, clinical remission of pericarditis occurs within about 4-6 weeks. This does not mean that pain must last for all of that time: it often improves much earlier, sometimes within the first few days of treatment. Rather, it means that complete resolution of the episode takes time and that disappearance of pain does not necessarily coincide with the end of inflammation.
Duration varies according to the cause, intensity of the inflammatory response, presence of effusion, possible myocardial involvement and response to treatment. Some people recover quickly, while others have persistent symptoms or experience a recurrence after a period of feeling well.

The acute pericarditis is the first episode or a newly occurring episode. If symptoms continue without true remission, the condition may become incessant pericarditis; if the episode resolves and later reappears, it is called recurrent pericarditis. This distinction is important because it changes the treatment pathway and the time needed to return to normal.

How long it takes for symptoms to improve

The symptom that tends to improve most quickly is chest pain. When the diagnosis is correct and anti-inflammatory treatment is effective, pain may decrease markedly within a few days. The speed of response, however, is not the same for everyone and should not be used to decide independently when to stop medication.
Fever and inflammatory markers, such as C-reactive protein, also tend to normalize with remission. The physician may use symptoms, blood tests and, in appropriate cases, imaging to determine whether inflammation is truly under control.

An initial improvement followed by renewed worsening of pain during treatment tapering does not necessarily mean a new disease. It may indicate that inflammation had not yet fully resolved. For this reason, treatment of pericarditis is not normally adjusted only according to the number of days that have passed, but according to the overall clinical response.
If no improvement is seen after about one week of adequate treatment with aspirin or an NSAID, the situation deserves reassessment because lack of response is considered a higher-risk feature and may require further investigation.

Why treatment may last longer than symptoms

In the acute episode, aspirin or an NSAID is generally used at an anti-inflammatory dose for a relatively short initial period and then tapered gradually according to the response. Colchicine, by contrast, is continued for longer precisely because its purpose is not only to reduce symptoms, but also to lower the risk that pericarditis returns.
The 2025 ESC guidelines indicate colchicine treatment for at least several months: typically at least 3 months after a first episode and at least 6 months in incessant or recurrent forms, with individualization according to the clinical picture. Dose and duration must in any case be defined by the physician, taking into account body weight, kidney function, drug interactions and tolerability.

This explains a common situation: the person feels well but continues treatment. This is not a contradiction. Disappearance of pain is an important goal, but prevention of recurrences requires the inflammatory process to reach stable remission.
Reducing or stopping medication independently because "it no longer hurts" can promote recurrence of symptoms. The risk is particularly relevant when therapy is tapered too quickly or when indicated colchicine is not taken for the prescribed duration.

When pericarditis lasts longer than expected

Not every case follows the classic course of a few weeks. The 2025 ESC guidelines define incessant pericarditis as a condition in which symptoms persist without a symptom-free interval longer than 4 weeks despite full treatment, or recur early while medication is being tapered. In these cases, it is important to reassess disease activity, adherence to and tolerability of treatment, possible specific causes and the presence of complications.
The term chronic pericarditis is used for conditions that persist for prolonged periods, whereas recurrent pericarditis describes episodes separated by a period of remission.

Recurrent pericarditis is one of the main reasons why the course can last for months. After a first episode, recurrence affects a meaningful proportion of patients and may occur even when the initial episode seemed completely resolved. The risk is greater when initial treatment was inadequate or tapered too quickly.
The presence of multiple recurrences does not automatically imply progressive heart damage, but it may require prolonged specialist management and, in cases resistant to first-line therapies, medications targeted at inflammation.

When recovery can be considered complete

Recovery should not be defined only by disappearance of pain. Clinical remission includes regression of symptoms and normalization or marked reduction of signs of disease activity. Depending on the case, C-reactive protein, ECG, echocardiogram and, in complicated or uncertain forms, cardiac magnetic resonance imaging may be considered.
MRI is not routinely necessary in every simple case of pericarditis, but it may be useful when the clinical picture is atypical, persistent or recurrent, when myocarditis is also suspected, or when inflammatory activity needs to be documented more clearly.

Return to work and normal daily activities depends on the type of activity and severity of the episode. For physical exercise the rule is even more important: disappearance of pain should not be used as the sole criterion for returning to training. Modern recommendations favor an individualized return after remission, with greater caution when myocardial involvement is present.
Practical management of return to activity is discussed in more detail in the guide pericarditis and physical activity.

Frequently asked questions about how long pericarditis lasts

How long does acute pericarditis last on average?
In uncomplicated forms, clinical remission often occurs within 4-6 weeks, although pain may improve much earlier.
How long does the pain last?
It may decrease within a few days with effective treatment, but duration is variable and its disappearance alone does not prove that inflammation has resolved.
When is pericarditis incessant?
When symptoms persist without a true symptom-free interval longer than 4 weeks despite full treatment, or recur early during medication tapering.

Can pericarditis return after recovery?
Yes. Recurrence is one of the most frequent complications. Colchicine, when indicated, reduces the risk of new episodes.
When can physical activity be resumed?
There is no number of days that applies to everyone. Return should occur after remission and according to medical advice, especially if there has been myocardial involvement.

Bibliography
  1. Schulz-Menger J, Collini V, Gröschel J, et al. 2025 ESC Guidelines for the management of myocarditis and pericarditis. European Heart Journal. 2025;46(40):3952-4041. doi:10.1093/eurheartj/ehaf192.
  2. Wang TKM, Klein AL, Cremer PC, et al. 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Diagnosis and Management of Pericarditis. Journal of the American College of Cardiology. 2025;86(25):2691-2719. doi:10.1016/j.jacc.2025.05.023.
  3. Klein AL, Wang TKM, Cremer PC, et al. Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging. JACC: Cardiovascular Imaging. 2024;17(8):937-988. doi:10.1016/j.jcmg.2024.04.010.
  4. Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. European Heart Journal. 2015;36(42):2921-2964. doi:10.1093/eurheartj/ehv318.
  5. Chiabrando JG, Bonaventura A, Vecchié A, et al. Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2020;75(1):76-92. doi:10.1016/j.jacc.2019.11.021.
  6. Imazio M, Brucato A, Cemin R, et al. A Randomized Trial of Colchicine for Acute Pericarditis. New England Journal of Medicine. 2013;369(16):1522-1528. doi:10.1056/NEJMoa1208536.
  7. Imazio M, Brucato A, Cemin R, et al. Colchicine for recurrent pericarditis (CORP): a randomized trial. Annals of Internal Medicine. 2011;155(7):409-414. doi:10.7326/0003-4819-155-7-201110040-00359.
  8. Imazio M, Belli R, Brucato A, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2). The Lancet. 2014;383(9936):2232-2237. doi:10.1016/S0140-6736(13)62709-9.
  9. Imazio M, Cecchi E, Demichelis B, et al. Indicators of poor prognosis of acute pericarditis. Circulation. 2007;115(21):2739-2744. doi:10.1161/CIRCULATIONAHA.106.662114.
  10. Spodick DH. Acute Pericarditis: Current Concepts and Practice. JAMA. 2003;289(9):1150-1153. doi:10.1001/jama.289.9.1150.

Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.

Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.